Average Insider

Where insiders trade, we follow

$IMNM
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Healthcare
Sector
Biotechnology
Industry
Clay Siegall
CEO
131
Employees
$27.99
Current Price
$2.03B
Market Cap
52W Low$8.66
Current$27.9999.7% above low, 0.3% below high
52W High$28.04

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00--All Sells
Sells26$5,412,918.40210,168
2 monthsBuys00--All Sells
Sells29$7,852,739.94311,260
3 monthsBuys13$204,260.0010,5001:77.74
Sells520$15,879,376.86692,810
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jun 5, 2026
BIENAIME JEAN JACQUES
Director
Sale500$19.44$9,720.00View Details
Jun 5, 2026
BIENAIME JEAN JACQUES
Director
Purchase6,000$19.48$116,880.00View Details
Jun 5, 2026
BIENAIME JEAN JACQUES
Director
Sale10,000$19.41$194,100.00View Details
15 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.7.3